Ozlem Tureci

Summary

Publications

  1. doi request reprint Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals
    Ozlem Tureci
    Ganymed Pharmaceuticals AG, Freiligrathstr Mainz, Germany
    Gene 481:83-92. 2011
  2. doi request reprint In silico strategy for detection of target candidates for antibody therapy of solid tumors
    Gerd Helftenbein
    Ganymed Pharmaceuticals AG, Mainz, Germany
    Gene 414:76-84. 2008

Collaborators

Detail Information

Publications2

  1. doi request reprint Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals
    Ozlem Tureci
    Ganymed Pharmaceuticals AG, Freiligrathstr Mainz, Germany
    Gene 481:83-92. 2011
    ..Given that CLDN18.2 is a novel drug target candidate, our data is also relevant for drug development as it reveals all six investigated mammalian species as suitable models for testing safety of CLDN18.2 targeting regimen...
  2. doi request reprint In silico strategy for detection of target candidates for antibody therapy of solid tumors
    Gerd Helftenbein
    Ganymed Pharmaceuticals AG, Mainz, Germany
    Gene 414:76-84. 2008
    ..The impact of such stringent input control on accuracy of prediction is underlined by RT-PCR confirmation of predicted tissue distribution patterns for a number of selected candidates...